Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis
✍ Scribed by Molly A. Sevcik; Nancy M. Luger; David B. Mach; Mary Ann C. Sabino; Christopher M. Peters; Joseph R. Ghilardi; Matthew J. Schwei; Heidi Röhrich; Carmen De Felipe; Michael A. Kuskowski; Patrick W. Mantyh
- Book ID
- 116817302
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 582 KB
- Volume
- 111
- Category
- Article
- ISSN
- 0304-3959
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Human recombinant tumor necrosis factor-alpha (rTNF-alpha, 10(-12)-10(-8) M) inhibited the proliferation of androgen-dependent LNCaP cells by 32-56%. In contrast, proliferation of androgen-independent PC-3 and JCA-1 cells was only slightly inhibited, or not inhibited at all, respectively. Human reco
Pain is the most common presenting symptom in patients with bone cancer and bone cancer pain can be both debilitating and difficult to control fully. To begin to understand the mechanisms involved in the generation and maintenance of bone cancer pain, we implanted 3 well-described murine tumor cell